medigraphic.com

2006, Número 2

<< Anterior Siguiente >>

Arch Cardiol Mex 2006; 76 (2)


Desencadenantes de síndromes coronarios agudos. Relaciones fisiopatológicas

González PJA

Idioma: Español
Referencias bibliográficas: 132
Paginas: 208-221
Archivo PDF: 157.98 Kb.


RESUMEN

El propósito de esta revisión, es analizar la relación entre los diversos estímulos externos disparadores y el desarrollo de síndromes coronarios agudos; se explican con base en las evidencias actuales, las interacciones fisiopatológicas entre ambos y se hacen propuestas preventivas a fin de impedir las consecuencias mórbidas y letales que su ocurrencia implica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. MARTÍNEZ-GONZÁLEZ J, LLORENTE-CORTÉZ V, BADIMON L: Biología celular y molecular de las lesiones ateroscleróticas. Rev Esp Cardiol 2001; 54: 218-231.

  2. LIBBY P, RIDKER PM, MASERI A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.

  3. BUFFON A, BIASUCCI LM, LLUSO G, D´ONOFRIO G, CREA F, MASERI A: Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12.

  4. TOFLER GH, STONE PH, MACLURE M, EDELMAN E, DAVIS VG, ROBERTSON T, ET AL: Analysis of possible triggers of acute myocardial infarction (The MILIS Study). Am J Cardiol 1990; 66: 22-27.

  5. SUMIYOSHI T, HAZE K, SAITO M, FUKAMI K, GOTO Y, HIRAMORI K: Evaluation of clinical factors involved in the onset of myocardial infarction. Jpn Circ J 1986; 50: 164-173.

  6. SMITH M, LITTLE WC: Potential precipitating factors of the onset of myocardial infarction. Am J Med Sci 1992; 303: 141-144.

  7. WILLICH SN, LEWIS M, LÖWEL H, ARNTZ H, SCHUBERT F, SCHRODER R, for The Triggers and Mechanisms of Myocardial Infarction Study Group: Physical exertion as a trigger of acute myocardial infarction. N Engl J Med 1993; 329: 1684-1690.

  8. MITTLEMAN MA, MACLURE M, TOFLER GH, SHERWOOD JB, GOLDBERG FJ, MULLER JE, for The Determinants of Myocardial Infarction Onset Study Investigators: Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. N Engl J Med 1993; 329: 1677-1683.

  9. MULLER J, WILLICH SN: Triggering of acute coronary syndromes. J Clin Basic Cardiol 2000; 3: 73-79.

  10. WANNAMETHEE G, SHAPER AG, MACFARLANE PW, WALKER M. Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995; 91: 1749-1756.

  11. GIRI S, THOMPSON PD, KIERNAN FJ, CLIVE J, FRAM DB, MITCHELL JF, ET AL: Clinical and angiographic characteristics of exertion-related acute myocardial infarction. JAMA 1999; 282: 1731-1736 (Erratum, JAMA 1999; 282: 2124).

  12. MITTLEMAN MA, SISCOVICK DS: Physical exertion as a trigger of myocardial infarction and sudden cardiac death. Cardiol Clin 1996; 14: 263-270.

  13. PFAFFENBARGER RS JR, HYDE RT, WING AI, LEE I, JUNG DL, KAMPERT JB: The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328: 538-545.

  14. MYERS J, PRAKASH M, FROELICHER V, DO D, PARTINGTON S, ATWOOD E: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793-801.

  15. JOLLIFE JA, REES K, TAYLOR RS, THOMPSON D, OLDRIDGE N, EBRAHIM S: Exercise based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001; CD001800.

  16. SESSO HD, PFAFFENBARGER RS JR, LEE IM: Physical activity and coronary heart disease in men. The Harvard Alumni Health Study. Circulation 2000; 102: 975-980.

  17. MANSON JE, GREENLAND P, LACROIX AZ, STEFANIK ML, MOUTON CHP, OBERMAN A, ET AL: Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002; 347: 716-725.

  18. ABETE P, FERRARA M, CACCIATORE F, SAGNELLI E, MANZI M, CARNOVALE V, ET AL: High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients. J Am Coll Cardiol 2001; 38: 1357-1365.

  19. BBC News, jul 09, 1992: Long hours linked to heart attacks.

  20. HEMINGWAY H, MARMOT H: Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999; 318: 1460-1467.

  21. WILLIAMS PB: Psychological factors in coronary heart disease: Epidemiological evidence. Circulation 1987; 76(Suppl I): I117-I123.

  22. KAWACHI I, COLDITZ GA, ASCHERIO A, RIMM EB, GIOVANNUCCI E, STAMPFER MJ, ET AL: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997.

  23. HAINES AP, IMESON JD, MEADE TW: Phobic anxiety and ischemic heart disease. BMJ 1987; 295: 297-299.

  24. HAINES A, COOPER J, MEADE TW: Psychological characteristics and fatal ischaemic heart disease. Heart 2001; 85: 385-389.

  25. PRATT LA, FORD DE, CRUM RM, ARMENIAN HK, GALLO JJ, EATON WW: Depression, psychotropic medication and risk of myocardial infarction. Prospective data from de Baltimore ECA followup. Circulation 1996; 94: 3123-3129.

  26. BAREFOOT JC, SCHROLL M: Symptoms of depression, acute myocardial and total mortality in a community sample. Circulation 1996; 93: 1976-1980.

  27. WASSERTHIEL-SMOLLER S, APPLEGATE WB, BERGE K, CHANG CHJ, DAVIS BR, GRIMM R, ET AL: Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch Intern Med 1996; 156: 553-561.

  28. BLOM M, JANSZKY I, BALOG P, ORTH-GOMER K, WAMALA S: Social relations in women with coronary heart disease: the effects of work and marital stress. J Cardiovasc Risk 2003; 10: 201-206.

  29. ORTH-GOMER K, WAMALA SP, HORSTEN M: Marital stress worsens prognosis in women with coronary heart disease: The Stockholm Female Coronary Risk Study. JAMA 2003; 284: 3008-3014.

  30. MATTHEWS KA, GUMP BS: Chronic work stress and marital dissolution increase risk post-trial mortality in men from de Multiple Risk Factor Intervention Trial. Arch Intern Med 2002; 162: 309-315.

  31. GALLO LC, TROXEL WM, KULLER LH, SUTTONTYRREL K, EDMUNDOWICZ D, MATTHEWS K: Marital status, marital quality, and atherosclerotic burden in postmenopausal women. Psychosom Med 2003; 65: 952-962.

  32. MULLER JE, MITTLEMAN MA, MACLURE M, SHERWOOD J, TOFLER GH: Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. JAMA 1996; 275: 1405-9.

  33. FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG, KRANE RJ, MCKINLAY JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.

  34. ZUSMAN RM: Cardiovascular data on sildenafil citrate: Introduction. Am J Cardiol 1999; 83: 1C-2C.

  35. Estadísticas de mortalidad en México: muertes registradas en el año 2002. Salud Pública Mex 2004; 46: 169-185.

  36. INEGI. XI Censo Nacional de Población y Vivienda,1990, y Conteo de Población y Vivienda, 1995.

  37. CHEITLIN MD, HUTTER AM, BRINDIS RG, GANZ P, KAUL S, RUSSELL RO, ET AL: ACC/AHA Expert Consensus Document. Use of Sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol 1999; 33: 273-282.

  38. Summary of Death Reports in Viagra received from marketing (late March) through June 1998. Washington, DC: Food and Drug Administration (Center of Drug Evaluation and Research); 1998.

  39. Viagra Deaths of Symptoms Leading to Death Occurring Within Tour to Five Hours. New York, NY. Pfizer Inc; 1998. Internal document.

  40. SUZUKI S, SAKAMOTO S, KOIDE M, FUJITA H, SAKURAMOTO H, KURODA T, ET AL: Hanshin-Awaji earthquake as a trigger for acute myocardial infarction. Am Heart J 1997; 134: 974-977.

  41. LEOR J, POOLE K, KLONER RA: Sudden cardiac deaths triggered by an earthquake. N Engl J Med 1996; 334: 413-419.

  42. KARIO K, OHASHI T, on behalf of the Tsuna Medical Association: Increased coronary heart disease mortality after the Hanshin-Awaji earthquake among the older community on Awaji Island. J Am Geriat Soc 1997; 45: 610-613.

  43. KLONER RA, LEOR J, POOLE WK, PERRIT R: Population-based analysis of the effects of the Northridge earthquake on cardiac death in Los Angeles County, California. J Am Coll Cardiol 1997; 30: 1174-1180.

  44. KARIO K: Does earthquake-induced cardiovascular disease persist or is it suppressed after the major quake? (letter). J Am Coll Cardiol 1998; 32: 553-554.

  45. BROWN DL: Disparate effects of the 1989 Loma Prieta and 1994 Northridge earthquakes on admissions for acute myocardial infarction: the importance of trigger time (abstr). Circulation 1997; 96 Suppl: I-291.

  46. MULLER JE, LUDMER PL, WILLICH SN, TOFLER GH, AYLMER G, KLANGOS I, ET AL: Circadian variation in the frequency of sudden cardiac death. Circulation 1987; 75: 131-138.

  47. MEISEL SR, KUTZ I, DAYAN KI, PAUZNER H, CHETBOUN I, ARBEL Y, ET AL: Effect of iraqui missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet 1991; 338: 660-661.

  48. KARK JD, GOLDMAN S, EPSTEIN L: Iraqui missile attacks on Israel. The association of mortality with a life-threatening stressor. JAMA 1995; 273: 1208-12.

  49. SCHWARTZ J: Air pollution and daily mortality: a review and meta-analysis. Environ Res 1994; 64: 36-52.

  50. SCHWARTZ J: Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology 1997; 8: 371-377.

  51. KATSOUYANNI K, TOULOUMI G, SPIX C, SCHWARTZ J, BALDUCCI F, MEDINA S, ET AL: Short-term effects of ambient sulphur dioxide and particulate matters on mortality in 12 European cities: results from a time series data from the APHEA project. BMJ 1997; 314: 1658-63.

  52. MORGAN G, CORBETT S, WLODARCZYK J, LEWIS P: Air pollution and daily mortality in Sydney, Australia, 1989 through 1993. Am J Public Health 1998; 88: 759-764.

  53. SCHWARTZ J, MORRIS R: Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol 1995; 142: 23-35.

  54. ABURTO V, LOOMIS O, BANGDIWALA S, SHY C, RASCÓN-PACHECO R: Ozone suspended particulates, and daily mortality in Mexico City. Am J Epidemiol 1997; 145: 258-268.

  55. RUIDAVETS J-B, COURNOT M, CASSADOU S, GIROUX M, MEYBECK M, FARRIÈRES J, ET AL: Ozone air pollution is associated with acute myocardial infarction. Circulation 2005; 111: 563-569.

  56. PETERS A, VON KLOT S, HEIER M, TRENTINAGLIA I, HÖRMAN A, WICHMANN E, ET AL: Exposure to traffic and the onset of myocardial infarction. N Engl J Med 2004; 351: 1721-1730.

  57. STONE PH: Triggering myocardial infarction. N Engl J Med 2004; 351: 1716-1718.

  58. BROOK RD, FRANKLIN B, CASCIO W, HONG Y, HOWARD G, LIPSETT M, ET AL: Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004; 109: 2655-2671.

  59. TOSTESON DC, GREENBAUM DS. Letter. N Engl J Med 2005; 352: 623.

  60. BURKE AP, FARB A, MALCOM GT, LIANG Y, SMIALEK J, VIRMANI R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1312-1314.

  61. BOLINDER G, ALFREDSSON L, ENGLUND A, DEFAIRE U: Smokeless tobacco use and increased cardiovascular mortality. Am J Public Health 1994; 84: 399-404.

  62. HUHTASAARI F, LUNDBERG V, ELIASSON M, JANLERT U, ASPLUND K: Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999; 34: 1784-1790.

  63. BENOWITZ NL: Snuff, nicotine and cardiovascular disease: implications for tobacco control. J Am Coll Cardiol 1999; 34: 1791-1793.

  64. FERNÁNDEZ CC, GONZÁLEZ CV, LUQUE CA, SÁNCHEZ DC: Análisis de 1,030 casos de cardiopatía isquémica. Aspectos clínico-demográficos. Rev Mex Cardiol 1992; 3: 118-122.

  65. MULLER JE, STONE PH, TURI ZG, RUTHERFORD JD, CZEISLER CA, PARKER C, ET AL: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315-1322.

  66. CANNON CP, MCGABE CH, STONE PH, SCHACTMAN M, THOMPSON B, THEROUX P, ET AL: Circadian variation in the onset of unstable angina and nonQ-wave acute myocardial infarction (the TIMI III registry and TIMI III B). Am J Cardiol 1997; 79: 253-259.

  67. SAYER JW, WILKINSON P, RANJADALAYAN K, RAY S, MARCHANT B, TIMMIS A: Attenuation or absence of circadian and seasonal rhythms of acute myocardial infarction. Heart 1997; 77: 325-329.

  68. COHEN MC, ROHTLA KM, LAVERY CE, MULLER JE, MITTLEMAN MA: Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997; 79: 1512-1516.

  69. WILLICH SN, LINDERER T, WEGSCHEIDER K, LEIZOROVICZ A, ALAMERCERY I, SCHRODER R: Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. Circulation 1989; 80: 853-858.

  70. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. Eur Heart J 1992; 13: 594-598.

  71. KONO T, MORITA H, NISHINA T, FUJITA M, HIROTA Y, KAWAMURA K, ET AL: Circadian variations of onset of acute myocardial infarction and efficacy of the thrombolytic treatment. J Am Coll Cardiol 1996; 27: 774-778.

  72. HANSEN O, JOHANSEN BW, GULLBERG B: Circadian distribution of onset of acute myocardial infarction in subgroups from analysis of 10,791 patients treated in a single center. Am J Cardiol 1992; 69: 1003-1008.

  73. VAN DER PALEN JM, DOGGEN CJ, BEAGLEHOLE R: Variation in the time and day of onset of myocardial infarction and sudden cardiac death. NZ Med J 1995; 108: 332-334.

  74. KRANTS DS, KOP WJ, GABBAY FH: Circadian variation of ambulatory myocardial ischemia. Triggering by daily activities and evidence for an endogenous circadian component. Circulation 1996; 93: 1364-1371.

  75. WILLICH SN, LEVY D, ROCCO MB, TOFLER GM, STONE PH, MULLER JE: Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801-806.

  76. PETERS RW, MITCHELL RB, BROOKS MM, ECHT DS, BARKER AH, CAPONE R, ET AL: Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). J Am Coll Cardiol 1994; 23: 283-289.

  77. HAUSMAN D, TRAPPE HJ, BARGHEER K, DANIEL WG, WENZLAFF P, LICHTLEN PR: Circadian variation of ventricular tachycardia in patients after myocardial infarction. J Am Coll Cardiol 1992; 19: 368A.

  78. ARNTZ HR, WILLICH SN, OEFF M, BRUGGEMANN T, STERN R, HEINZMANN A, ET AL: Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation. Circulation 1993; 88: 2284-2289.

  79. BEHAR S, HALABI M, REICHERA-REISS H, ZION M, KAPLINZKY E, GOLDBOURT U: Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med 1993; 94: 395-400.

  80. ARNTZ HR, MULLER J, WILLICH SN: Cold Monday mornings prove dangerous: epidemiology of sudden cardiac death. Curr Op Crit Care 2001; 7: 139-144.

  81. WILLICH SN, LOWEL H, LEWIS M, HORMANN A, ARNTZ HR, KEIL U: Weekly variation of acute myocardial infarction. Increased Monday risk in the working population. Circulation 1994; 90: 87-93.

  82. MARCHANT B, RANJADAYALAN K, STEVENSON R, WILKINSON P, TIMMIS AD: Circadian and seasonal factors in the pathogenesis of acute myocardial infarction: the influence of environmental temperature. Br Heart J 1993; 69: 385-387.

  83. SPENCER FA, GOLDBERG RJ, BECKER RC, GORE JM: Seasonal distribution of acute myocardial infarction in the Second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998; 31: 1226-1233.

  84. GONZÁLEZ HE, CABADÉS OA, CEBRIÁN DJ, LÓPEZ MB, SANJUÁN MR, ECHÁNOVE EI, ET AL: Variaciones estacionales en los ingresos por infarto agudo del miocardio. El estudio PRIMVAC. Rev Esp Cardiol 2004; 57: 12-19.

  85. GABBAY FH, KRANTZ DS, KOP WJ, HEDGES SM, KLEIN J, GOTTDIENER JS, ET AL: Triggers of myocardial ischemia during daily life in patients with coronary artery disease: physical and mental activities, anger and smoking. J Am Coll Cardiol 1996; 27: 585-592.

  86. MEADE TW, IMESON J, STIRLING Y: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; 2: 986-988.

  87. BENOWITZ NL, FITZGERALD GA, WILSON M, ZHANG QI: Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993; 22: 1159-1167.

  88. JERN C, ERIKSON E, TENGBORN L, RISBERT B, WADENVIK H, JERN S: Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62: 767-771.

  89. DAVIES MJ, THOMAS AC: Plaque fissuring – the cause of myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53: 363-373.

  90. WAXMAN S, MULLER JE: Risk factors for an acute ischemic event. En: Braunwald E, Califf RM (eds.). Atlas of heart diseases. Acute myocardial infarction and other acute ischemic syndromes. 2nd Ed. Philadelphia. Current Medicine, 2001: 21-35.

  91. SHAH PK: Plaque disruption and coronary thrombosis: new insight into pathogenesis and prevention. Clin Cardiol 1997; 20(Suppl 2): II38-II44.

  92. STEIN PD, HAMID MS, SHIVKUMAR K, DAVIS TP, KHAJA F, HENRY JW: Effects of cyclic flexion of coronary arteries on progression of atherosclerosis. Am J Cardiol 1994; 73: 431-437.

  93. DOUSTE-BLAZY P, SIE P, BONEU B, MARCO J, ECHE N, BERNADET P: Exercise-induced platelet activation in myocardial infarction survivors with normal coronary arteriogram. Thromb Haemostas 1984; 52: 297-300.

  94. KESTIN AS, ELLIS PA, BARNARD MR, ERRICHETTI A, ROSNER BA, MICHELSON AD: Effect of strenuous exercise on platelet activation state and reactivity. Circulation 1993; 88: 1502-1511.

  95. LEVIN SP, TOWELL BL, SUAREZ AM, KNIERIEM LK, HARRIS MM, GEORGE JN: Platelet activation and secretion associated with emotional stress. Circulation 1985; 71: 1129-1134.

  96. FLETCHER GF, BALADY GT, AMSTERDAM EA, CHAITMAN B, ECKEL R, FLEG J, ET AL: Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740.

  97. BORAITA A: La práctica deportiva mejora el perfil lipídico plasmático, pero ¿a cualquier intensidad? Rev Esp Cardiol 2004; 57: 495-498.

  98. THOMPSON PD, CROUSE SF, GOODPASTER B, KELLEY D, MOYNA N, PESCATELLO L: The acute versus the chronic response to exercise. Med Sci Sports Exerc 2001; 33:Suppl: S438-S445.

  99. BALADY GJ: Survival of the fittest –more evidence. N Engl J Med 2002; 346: 852-854.

  100. RAURAMAA R, SALONEN JT, SEPPANEN K, SALONEN R, VENALAINEN JM, IHANAINEN M, ET AL: Inhibition of platelet aggregability by moderate-intensity physical exercise; a randomized clinical trial in overweight men. Circulation 1986; 74: 939-944.

  101. SMITH JK, DYKES R, DOUGLAS JE, KRISHNASWAMY G, BERK S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999; 281: 1722-1727.

  102. WINTHER K, HILLEGRASS W, TOFLER GH, JIMENEZ A, BREZINSKI DA, SCHAFER A, ET AL: Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men. Am J Cardiol 1992; 70: 1051-1055.

  103. KAWACHI I, SPARROW D, VOKONAS PS, WEISS ST: Decreased heart rate variability in men with phobic anxiety. Am J Cardiol 1995; 75: 882-885.

  104. BOLTWOOD MD, BARR TAYLOR C, BOUTTE´ BURKE M, GROGIN H, GIACOMINI J: Anger report predicts coronary artery vasomotor response to mental stress in artherosclerotic segments. Am J Cardiol 1993; 72: 1361-1365.

  105. BURG MM, JAIN D, SOUFIER R, KERNS RD, ZARET BL: Role of behavioral and psychological factors in mental stress induced left ventricular dysfunction in coronary artery disease. J Am Coll Cardiol 1993; 22: 440-448.

  106. PITZALIS MV, IACOVIELLO M, TODARELLO O, FIORETTI A, GUIDA P, MASSARI F, ET AL: Depression but not anxiety influence the autonomic control of heart rate after myocardial infarction. Am Heart J 2001; 141: 765-771.

  107. SCHINS A, HONIG A, CRIJNS H, BAUR L, HAMULYAK K: Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link? Psychosom Med 2003; 65: 729-737.

  108. FENG CJ, TOFLER GH: Diurnal physiological processes and circadian variation of acute myocardial infarction. J Cardiovasc Risk 1995; 2: 494-498.

  109. ANDREOTTI F, KLUFT C, DAVIES GJ, HUISMAN LG, DE BART AC, MASERI A: Effect of propranolol (longacting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1. Am J Cardiol 1991; 68: 1295-1299.

  110. KURNIK RP: Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation 1995; 91: 1341-1346.

  111. PETERS A, DORING A, WICHMANN HE, KOENIG W: Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet 1997; 349: 1582-1587.

  112. MEANEY E, RIVERA JM, SCHUCHLEIB R, GÓMEZ AE: Aterosclerosis y sus precursores (B-4). Programa de actualización continua para el cardiólogo. Intersistemas. México, 1998: 41-44.

  113. PENN A, ZINDER CA: 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates artherosclerotic plaque development. Circulation 1997; 93: 275-276.

  114. SMITH CJ, FISCHER TH: Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 2001; 158: 257-267.

  115. BENOWITZ NL, GOURLAY SG: Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997; 29: 1422-1431.

  116. WENNMALM A, BENTHIN G, GRANSTRÖM EF, PERSSON L, PETERSSON AS, WINELL S: Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 1991; 83: 1698-1704.

  117. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989-995.

  118. MURRAY RP, BAILEY WC, DANIELS K, BJORNSON WM, KURNOW K, KONNETT J, ET AL: Safety of nicotin polacrilex gum used by 3,094 participants in the Lung Health Study. Chest 1996; 109: 438-445.

  119. MAHMARIAN JJ, MOYÉ LA, NASSER GA, NAGUEH SF, BLOOM MF, BENOWITZ NL, ET AL: Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 1997; 30: 125-130.

  120. BARUA RS, AMBROSE JA, EALES-REYNOLDS LJ, DEVOE MC, ZERVAS JG, SAHA DC: Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity. An in vivo and in vitro correlation. J Am Coll Cardiol 2002; 39: 1758-1763.

  121. MCGILL HC: The cardiovascular pathology of smoking. Am Heart J 1988; 115: 250-257.

  122. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol 1996; 27: 957-1047.

  123. BETANCOURT L, NAVARRO RJ: Tabaquismo. Panorama general y perspectivas. Rev Mex Cardiol 2001; 12: 85-93.

  124. YEH CJ, CHAN P, PAN WH: Values of blood coagulation factors vary with ambient temperature: the Cardiovascular Disease Risk Factor TwoTownship Study in Taiwan. Chin J Physiol 1996; 39: 111-116.

  125. THOMPSON PD: Additional steps for cardiovascular health. N Engl J Med 2002; 347: 755-756.

  126. ROZANSKI A, BLUMENTHAL JA, DAVIDSON KW, SAAB PG, KUBZANSKY L: The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. The emerging field of Behavioral Cardiology. J Am Coll Cardiol 2005; 45: 637-651.

  127. CANALE JM, BUSTAMANTE F: Uso de sildenafil en hombres con cardiopatía coronaria: consideraciones clínicas y epidemiológicas. Rev Mex Cardiol 1999; 10: 85-89.

  128. ANTMAN EM, ANBE DT, ARMSTRONG PW, BATES ER, GREEN LA, HAND M, ET AL: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 Guidelines for the Management of patients with Acute Myocardial Infarction). 2004 update;http://www.acc.org/clinical/statements.htm

  129. BRAUNWALD E, ANTMAN EM, BEASLEY JW, CALIFF RM, CHEITLIN MD, HOCHMAN JS, ET AL: ACC/AHA 2002 guideline update for the management of the patients with unstable angina and non-STsegment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of patients with Unstable Angina). 2002 update;http://www.acc.org/clinical/statements.htm

  130. RIDKER PM, MANSON JE, BURING JE, MULLER JE, HENNEKENS CH: Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990; 82: 897-902.

  131. HUNG J, LAM JY, LACOSTE L, LETCHACOVSKI G: Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92: 2432-2436.

  132. SMITH SC, BLAIR SN, BONOW RO, BRASS LM, CERQUEIRA MD, DRACUP K, ET AL: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001; 104: 1577-1579.




2020     |     www.medigraphic.com